These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33332701)

  • 1. Synthetic Phenolic Glycolipids for Application in Diagnostic Tests for Leprosy.
    van Dijk JHM; van Hooij A; Groot LM; Geboers J; Moretti R; Verhard-Seymonsbergen E; de Jong D; van der Marel GA; Corstjens PLAM; Codée JDC; Geluk A
    Chembiochem; 2021 Apr; 22(8):1487-1493. PubMed ID: 33332701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.
    Spencer JS; Brennan PJ
    Lepr Rev; 2011 Dec; 82(4):344-57. PubMed ID: 22439275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae.
    Bobosha K; Tjon Kon Fat EM; van den Eeden SJ; Bekele Y; van der Ploeg-van Schip JJ; de Dood CJ; Dijkman K; Franken KL; Wilson L; Aseffa A; Spencer JS; Ottenhoff TH; Corstjens PL; Geluk A
    PLoS Negl Trop Dis; 2014 May; 8(5):e2845. PubMed ID: 24810599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and Monitoring of
    Zhou Z; Pena M; van Hooij A; Pierneef L; de Jong D; Stevenson R; Walley R; Corstjens PLAM; Truman R; Adams L; Geluk A
    Front Microbiol; 2021; 12():763289. PubMed ID: 34777319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingerstick test quantifying humoral and cellular biomarkers indicative for M. leprae infection.
    Corstjens PLAM; van Hooij A; Tjon Kon Fat EM; Alam K; Vrolijk LB; Dlamini S; da Silva MB; Spencer JS; Salgado CG; Richardus JH; van Hees CLM; Geluk A
    Clin Biochem; 2019 Apr; 66():76-82. PubMed ID: 30695682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of enzyme immunoassays based on synthetic glycoconjugates and phenolic glycolipid-I for immunodiagnosis of leprosy.
    Moudgil KD; Mishra R; Talwar GP
    Indian J Lepr; 1990; 62(1):60-5. PubMed ID: 2193062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
    Chujor CS; Bernheimer H; Levis WR; Schwerer B
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients.
    Britton WJ; Garsia RJ; Basten A
    Aust N Z J Med; 1987 Dec; 17(6):568-73. PubMed ID: 3328975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
    Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of synthetic glycoconjugates as components of the immunochromatographic test for rapid serological diagnosis of leprosy.].
    Korolyova-Ushakova AG; Baranova EV; Ignatov SG; Fedyukina GN; Solov'ev PV; Kolombet LV; Biketov SF
    Klin Lab Diagn; 2020; 65(5):289-293. PubMed ID: 32298544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Anti-Phenolic Glycolipid-I antibody in sera from tuberculosis patients in Bandung, West Java, Indonesia.
    Gunawan H; Roslina N; Agusni JH; Kulsum ID; Makarti K; Hindritiani R; Suwarsa O
    Int J Mycobacteriol; 2019; 8(2):166-169. PubMed ID: 31210160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier.
    Moura RS; Penna GO; Fujiwara T; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Cardoso LP; Stefani MM; Bührer-Sékula S
    J Immunol Methods; 2014 Oct; 412():35-41. PubMed ID: 24983877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
    Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
    FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies to both M. leprae PGL-I and MMP-II to recognize leprosy patients at an early stage of disease progression.
    Wang H; Liu W; Jin Y; Yu M; Jiang H; Tamura T; Maeda Y; Makino M
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):274-7. PubMed ID: 26320400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.